Alaunos Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Alaunos Therapeutics, Inc. (TCRT) reported Basic Shares Outstanding (Weighted Average) of 2.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 2.43M shares, a 45.06% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 1.95M shares, a 21.68% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 2.33M shares, a 45.26% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.18M shares, a 36.33% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 1.95M shares, a 21.68% increase from fiscal 2024.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.60M shares, a 0.11% increase from fiscal 2023.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.60M shares, a 88.95% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 14.48M shares, a 93.25% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.43M shares 10-Q · filed 2026-08-14 | 2.40M shares 10-Q · filed 2026-08-14 | 2.24M shares derived: average of 3 quarters · filed 2026-08-14 | 2.22M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 1.95M shares 10-Q · filed 2026-05-15 | 2.14M shares derived: average of 2 quarters · filed 2026-05-15 | 2.15M shares derived: average of 3 quarters · filed 2026-05-15 | 2.03M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 2.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.25M shares derived: average of 2 quarters · filed 2026-03-31 | 2.06M shares derived: average of 3 quarters · filed 2026-08-14 | 1.95M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 2.18M shares 10-Q · filed 2025-11-14 | 1.93M shares derived: average of 2 quarters · filed 2026-08-14 | 1.82M shares 10-Q · filed 2025-11-14 | 1.77M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 1.68M shares 10-Q · filed 2026-08-14 | 1.64M shares 10-Q · filed 2026-08-14 | 1.63M shares derived: average of 3 quarters · filed 2026-08-14 | 1.62M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 1.60M shares 10-Q · filed 2026-05-15 | 1.60M shares derived: average of 2 quarters · filed 2026-05-15 | 1.60M shares derived: average of 3 quarters · filed 2026-05-15 | 1.60M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 1.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.60M shares derived: average of 2 quarters · filed 2026-03-31 | 1.60M shares derived: average of 3 quarters · filed 2026-03-31 | 1.60M shares 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | 1.60M shares 10-Q · filed 2025-11-14 | 1.60M shares derived: average of 2 quarters · filed 2025-11-14 | 1.60M shares 10-Q · filed 2025-11-14 | 1.60M shares derived: average of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | 1.60M shares 10-Q · filed 2025-08-14 | 1.60M shares 10-Q · filed 2024-08-14 | 1.60M shares 10-Q · filed 2025-08-14 | 1.60M shares derived: average of 3 quarters · filed 2025-08-14 | 1.60M shares derived: average of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | 1.60M shares 10-Q · filed 2025-05-15 | 16.01M shares 10-Q · filed 2024-05-15 | 1.60M shares derived: average of 2 quarters · filed 2025-05-15 | 1.60M shares derived: average of 3 quarters · filed 2025-05-15 | 1.60M shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | 1.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.60M shares derived: average of 2 quarters · filed 2025-03-31 | 1.60M shares derived: average of 3 quarters · filed 2025-03-31 | 1.60M shares 10-K · filed 2025-03-31 | 16.00M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 1.60M shares 10-Q · filed 2024-11-14 | 240.05M shares 10-Q · filed 2023-11-14 | 1.60M shares derived: average of 2 quarters · filed 2024-11-14 | 1.60M shares 10-Q · filed 2024-11-14 | 239.84M shares 10-Q · filed 2023-11-14 | -141.99M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 1.60M shares 10-Q · filed 2024-08-14 | 239.80M shares 10-Q · filed 2023-08-14 | 1.60M shares 10-Q · filed 2024-08-14 | 239.74M shares 10-Q · filed 2023-08-14 | -189.86M shares derived: average of 3 quarters · filed 2024-08-14 | -88.62M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 15.98M shares 10-Q · filed 2024-05-15 | 239.68M shares 10-Q · filed 2023-05-10 | -285.58M shares derived: average of 2 quarters · filed 2024-05-15 | -118.69M shares derived: average of 3 quarters · filed 2024-05-15 | -35.27M shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -587.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -186.02M shares derived: average of 2 quarters · filed 2024-04-01 | -52.35M shares derived: average of 3 quarters · filed 2024-04-01 | 14.48M shares 10-K · filed 2024-04-01 | 217.13M shares 10-K · filed 2023-03-07 | |||
| 2022-09-30 | 215.10M shares 10-Q · filed 2023-11-14 | 215.05M shares derived: average of 2 quarters · filed 2023-11-14 | 215.02M shares 10-Q · filed 2023-11-14 | 214.93M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 215.00M shares 10-Q · filed 2023-08-14 | 214.97M shares 10-Q · filed 2023-08-14 | 214.87M shares derived: average of 3 quarters · filed 2023-08-14 | 214.79M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 214.95M shares 10-Q · filed 2023-05-10 | 214.81M shares derived: average of 2 quarters · filed 2023-05-10 | 214.72M shares derived: average of 3 quarters · filed 2023-05-10 | 214.65M shares derived: average of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 214.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | 214.60M shares derived: average of 2 quarters · filed 2023-03-07 | 214.54M shares derived: average of 3 quarters · filed 2023-03-07 | 214.40M shares 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | 214.54M shares 10-Q · filed 2022-11-14 | 214.48M shares derived: average of 2 quarters · filed 2022-11-14 | 214.31M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 214.43M shares 10-Q · filed 2022-08-15 | 214.19M shares 10-Q · filed 2022-08-15 | ||||||
| 2020-12-31 | 209.64M shares 10-K · filed 2022-03-30 | |||||||
| 2019-12-31 | 167.95M shares 10-K · filed 2021-03-01 | |||||||
| 2018-12-31 | 143.51M shares 10-K · filed 2021-03-01 | |||||||
| 2017-12-31 | 136.94M shares 10-K · filed 2020-03-02 | |||||||
| 2016-12-31 | 130.39M shares 10-K · filed 2019-03-05 | |||||||
| 2012-09-30 | 78.67M shares 10-Q · filed 2012-11-08 | 78.59M shares derived: average of 2 quarters · filed 2012-11-08 | 77.61M shares 10-Q · filed 2012-11-08 | |||||
| 2012-06-30 | 78.51M shares 10-Q/A · filed 2012-08-28 | 77.07M shares 10-Q/A · filed 2012-08-28 | ||||||
| 2011-09-30 | 68.10M shares 10-Q · filed 2012-11-08 | 67.67M shares derived: average of 2 quarters · filed 2012-11-08 | 65.28M shares 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | 67.23M shares 10-Q/A · filed 2012-08-28 | 63.84M shares 10-Q/A · filed 2012-08-28 | ||||||
| 2010-09-30 | 47.43M shares 10-Q · filed 2011-11-03 | 44.90M shares derived: average of 2 quarters · filed 2011-11-03 | 43.33M shares 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | 42.36M shares 10-Q/A · filed 2011-08-09 | 41.25M shares 10-Q/A · filed 2011-08-09 | ||||||
| 2009-09-30 | 21.76M shares 10-Q · filed 2011-08-01 | 21.46M shares 10-Q · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |